Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Pediatric Dermatology: Therapeutic and Diagnostic Pearls

Description

The presentation on Pediatric Dermatology focuses on essential therapeutic and diagnostic insights for practitioners in pediatric dermatology. The speaker addresses the significant access issues in pediatric dermatology, highlighting the limited number of board-certified pediatric dermatologists and the restricted availability of FDA-approved medications for children. The discussion emphasizes various skin conditions like acne, alopecia, eczema, and their treatment using both old and new methods while advocating for shared decision-making with parents. A central theme is treating atopic dermatitis, where the speaker elaborates on various topical treatments including hydrocortisone, triamcinolone, and mometasone, and the importance of addressing parental concerns about steroid use. The presentation notes the relevance of considering patient-specific factors such as anxiety levels and preferences while prescribing treatments. In addition to eczema, the speaker covers the management of skin infections, including the importance of proper culturing techniques, alongside therapies for molluscum and warts. The session concludes with a call to action for dermatologists to increase their engagement in pediatric dermatology, improve accessibility to treatments, and embrace the potential benefits of off-label medication use.

View more

Conclusions

  • Access to pediatric dermatology services and medications is a significant issue that needs addressing.
  • Pediatric dermatologists treat a wide range of skin conditions, including eczema, acne, and infections.
  • Effective management of atopic dermatitis requires shared decision-making with parents and addressing their concerns such as steroid phobia.
  • Topical corticosteroids remain a key component in managing eczema and other pediatric dermatological conditions, especially under FDA guidelines.
  • New therapies and treatment methods for pediatric dermatology are emerging, providing more options for effective management.
  • Meta-analysis shows that moderate-potency topical corticosteroids, along with pimecrolimus and tacrolimus, are effective in both improving and maintaining eczema control across various patient demographics.
  • Understanding parental preferences and engaging in open communication can enhance treatment adherence and outcomes for pediatric dermatological issues.
  • Freeze ME, Balogh EA, Cline A, Feldman SR, Fleischer AB Jr. Comparing prescribing patterns for topical corticosteroids based on their FDA indication by age. Pediatr Dermatol. 2021 Jan;38(1):115-118. doi: 10.1111/pde.14442. Epub 2020 Nov 10. PMID: 33170543.
  • Chu DK, et al. Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. J Allergy Clin Immunol. 2023 Dec;152(6):1493-1519. doi: 10.1016/j.jaci.2023.08.030. Epub 2023 Sep 9. PMID: 37678572.
  • Harvey J, Lax SJ, Lowe A, Santer M, Lawton S, Langan SM, Roberts A, Stuart B, Williams HC, Thomas KS. The long-term safety of topical corticosteroids in atopic dermatitis: A systematic review. Skin Health Dis. 2023 Aug 16;3(5):e268. doi: 10.1002/ski2.268. PMID: 37799373; PMCID: PMC10549798.